Recon: Lilly's weight loss pill shows disappointing results; FDA moves to boost US drug manufacturing

• As mRNA falls out of favor for HHS, are cancer vaccines next? (STAT)
• Work on mRNA therapies was surging. Now Kennedy has rocked the field (STAT)
• US FDA announces new program to boost domestic drug manufacturing (Reuters)
• US FDA Requires Opioid Class Labeling Changes Despite Adcomm Advice (Pink Sheet)
• US FDA Skips User Fee Increase For More Staff Amid Exodus, Hiring Difficulties (Pink Sheet)
• Some Common Medications Have a Little-Known Side Effect (Bloomberg)
• Trump, pharma industry discuss boosting medicine spending abroad to cut US prices, sources say (Reuters)

• Danish drugmakers jump as Eli Lilly's weight-loss pill data disappoints (Reuters) (Bloomberg)
• Chinese biotech Minghui raises $131M to advance its PD-1xVEGF bispecific (Endpoints)
• Titanium Dioxide Stays: EU Decides Not To Pull Plug On Widely Used Excipient (Pink Sheet)
• England: Pharma Firms To Benefit From Parallel HTA And Regulatory Pathway (Pink Sheet)
• Merck KGaA Is Latest Drugmaker to Weigh Direct US Patient Sales (Bloomberg)

• Alnylam could be the next mega-cap biotech (STAT)
• Eli Lilly’s much-anticipated obesity pill yields modest results (STAT) (Reuters)
• Superagers’ brains offer clues to cognitive resilience, and possible treatments, researchers say (STAT)
• Lithium, a treatment for bipolar disorders, might be a key to Alzheimer’s disease (STAT)
• Xanax-maker Viatris beats quarterly profit, revenue estimates; shares rise (Reuters)
• Sarepta hired a Trump-connected firm to lobby on Duchenne treatment (STAT)
• Scholar Rock expects September PDUFA for spinal muscular atrophy drug to stay unchanged despite CDMO woes (Endpoints)
• Exclusive: Translucent raises $7M for AI to analyze financial performance (Endpoints)
• FDA lifts pause of Valneva's chikungunya vaccine in older adults (Fierce Pharma)

• The companies that pledged to build patient AI assistant apps (STAT)
• FTC moves to block Edwards’ JenaValve acquisition (MedTech Dive)
• BD commits $35M to expand US syringe production plant (MedTech Dive)
• Zimmer Biomet raises annual profit forecast on lower tariff impact (Reuters)
• PathAI Talks PCCPs: ‘Accelerated Software Updates, Saves Time And Money’ (MedTech Insight)
• SpotitEarly Sets Up US HQ, Launches Trials For Dog- And AI-Powered Early Cancer Detection Test (MedTech Insight)
• Additional Death And Injuries Added To 2024 Philips Ventilator Recall (MedTech Insight)
• Insulet beats second-quarter profit estimates on strong demand for insulin pumps (Reuters)

• Ultra-Processed Foods Make Up More Than 60% of US Kids’ Diets (Bloomberg)
• Raw milk tied to over 21 illness cases in Florida: Here's why (The Hill)

• Wyden, Warren launch investigation into UnitedHealth’s nursing home practices (STAT)
• CDC adopts advisors' recommendation for Merck’s infant RSV antibody (Endpoints)
• Planned Parenthood to close Louisiana clinics (The Hill)